| Name | Title | Contact Details |
|---|
Cerami is a Belleville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carta empowers hospitals to personalize the delivery of care to the individual needs of each patient. Our insight here is that personalizing care is not only good from an outcome/clinical perspective (where most people focus in the context of personalization) but is also the best way to optimize operations. Currently, hospitals have to over provision their resources because they are set up to serve the generic patient; planning ahead for exactly the resources needed– no more, no less– is the best way to gain efficiency. The approach we`re advocating and enabling is to: 1) Find past patients similar to the current one being treated 2) Quantify what exactly happened to them during their journey through the hospital (this is where our model comes in) 3) Use machine learning to project what the particular patient in question will need, and what the patient can expect their experience to be in the hospital We`re applying this approach now to two use cases– supplies projection and bed usage projection– and we have a bunch of other use cases we`re planning on addressing in the future.
Southwestern Health Resources, which blends the strengths of University of Texas Southwestern Medical Center and Texas Health Resources, includes a network of 29 hospital locations and more than 5,000 physicians, committed to being the national leader in population health. With more than 500 points of access to care, this provides for higher value and allows patients to access services across a full continuum of medical needs. The network serves people across 17 counties in North Texas. In total, Southwestern Health coordinates care for more than 650,000 patients, aligned with commercial health care plans and Medicare programs. SWHR operates the nation`s highest rated Next Generation Accountable Care Organization for savings.
Test Equipment Distributors is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NeoChord is a venture backed medical device company that has developed a proprietary device which allows mitral valve repair to be performed on a beating heart through a 2- to 3-inch incision between the ribs in patients with severe mitral valve regurgitation (MR). In contrast, most mitral valve repair procedures are performed through a 3 to 10 inch chest incision (sternotomy) that involves cutting through the sternum, opening the rib cage, stopping the heart and placing the patient on cardio-pulmonary bypass (CPB).